PCMM
TEVA icon

Private Capital Management (Minnesota)’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Private Capital Management (Minnesota)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$459K Buy
26,100
+8,850
+51% +$199K 0.52% 90
2017
Q2 		$573K Buy
17,250
+2,550
+17% +$78.9K 0.64% 54
2017
Q1 		$472K Buy
14,700
+1,100
+8% +$37.5K 0.52% 85
2016
Q4 		$493K Sell
13,600
-600
-4% -$24K 0.55% 73
2016
Q3 		$654K Buy
14,200
+5,000
+54% +$261K 0.69% 56
2016
Q2 		$462K Buy
+9,200
New +$490K 0.46% 96

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Private Capital Management (Minnesota)'s TEVA Position: Q3 2017 in Review

Private Capital Management (Minnesota) increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 51% in Q3 2017, buying an estimated $199K and bringing the position to 26,100 shares worth $459K. The position accounts for 0.52% of the portfolio, ranked #90.

Private Capital Management (Minnesota) first reported a position in TEVA in Q2 2016 and has held it in 6 quarters since. The position peaked at $654K in Q3 2016. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Private Capital Management (Minnesota) held 26,100 shares of Teva Pharmaceutical Industries Limited worth $459K as of Q3 2017.
  • Private Capital Management (Minnesota) bought 8,850 Teva Pharmaceutical Industries Limited shares in Q3 2017, an estimated $199K.
  • Teva Pharmaceutical Industries Limited made up 0.52% of Private Capital Management (Minnesota)'s portfolio in Q3 2017, its #90 holding.
  • Private Capital Management (Minnesota) first reported a position in Teva Pharmaceutical Industries Limited in Q2 2016 and has held it in 6 quarters since.
  • Private Capital Management (Minnesota)'s Teva Pharmaceutical Industries Limited position peaked at $654K in Q3 2016.
  • 537 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2017.

Based on Private Capital Management (Minnesota)'s 13F filing for Q3 2017, filed 26 Oct 2017.